Latest News
Venus Remedies Limited
- Venus Remedies receives five marketing approvals In Kazakhstan, Peru, Kuwait, Argentina
- Venus Remedies secures 5 marketing authorisations in 4 global markets
- Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
- Venus Remedies VENUSREM Secures Five Marketing Authorisations
- Is Venus Remedies the Best Stock in Its Sector? A Look at the Numbers
- Venus Remedies Yearly results, Financial Summary
- Venus Remedies Slips Over 4%: VENUSREM.NS Retreats Toward Key Support - Swing Entry Signals
- Venus Remedies VENUSREM Q2 FY27 Regulation 74(5) Compliance
- Venus Remedies Lower Circuit Today: Price, Data and Peers
- Venus Remedies (VENUSREM.NS) Falls 5% to ₹1,681 as Pharma Stock Retreats Toward ₹1,597 Support - Factor Timing
- Venus Remedies (VENUSREM.NS) Slips 1.04% to ₹1778, Holding Above ₹1689 Support - Volatility Surface
- Venus Remedies Ltd. Upper Circuit Today: Price, Data and Peers
Headlines from the last 30 days, linking to the original publishers. See all market news →